| Identification | Back Directory | [Name]
(-MDA-d3 (hydrochloride) | [CAS]
2747917-68-4 | [Synonyms]
(-MDA-d3 (hydrochloride)
(±)-MDA-d3 (hydrochloride)
(±)-MDA-d3 (hydrochloride) (exempt preparation)
α-methyl-1,3-benzodioxole-5-ethanamine-d3,monohydrochloride | [Molecular Formula]
C10H11ClD3NO2 | [MOL File]
2747917-68-4.mol | [Molecular Weight]
218.695 |
| Hazard Information | Back Directory | [Description]
(±)-MDA-d3 (hydrochloride) (exempt preparation) (Item No. 22875) is an analytical reference standard intended for use as an internal standard for the quantification of (±)-MDA (Item Nos. ISO60189 | 11554) by GC- or LC-MS. (±)-MDA is categorized as an amphetamine.1,2 It induces the head-twitch response (HTR) in mice, indicating hallucinogenic potential.2 (±)-MDA has been found in seized ecstasy tablets.3 (±)-MDA-d3 is regulated as a Schedule I compound in the United States. (±)-MDA-d3 (hydrochloride) (exempt preparation) (Item No. 22875) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [Description]
(±)-MDA-d3 (hydrochloride) (Item No. 15820) is an analytical reference standard intended for use as an internal standard for the quantification of (±)-MDA (Item Nos. ISO60189 | 11554) by GC- or LC-MS. (±)-MDA is categorized as an amphetamine.1,2 It induces the head-twitch response (HTR) in mice, indicating hallucinogenic potential.2 (±)-MDA has been found in seized ecstasy tablets.3 (±)-MDA-d3 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [References]
[1] R. DE LA TORRE. Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans[J]. British journal of clinical pharmacology, 2002, 49 2: 104-109. DOI: 10.1046/j.1365-2125.2000.00121.x
[2] ADAM L. HALBERSTADT . Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species[J]. Neuropharmacology, 2020, 167: Article 107933. DOI: 10.1016/j.neuropharm.2019.107933
[3] JACK YUK KI CHENG. Impurity profiling of ecstasy tablets seized in Hong Kong by gas chromatography–mass spectrometry[J]. Forensic science international, 2006, 162 1: Pages 87-94. DOI: 10.1016/j.forsciint.2006.02.055 |
|
|